輸入代號或公司名稱後按 Enter
4160

訊聯基因

+0.25 (+0.64%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
39.1514成交張數58.43本益比2.12股價淨值比1.27%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q20.22187.7%0.640.064.1%1.23%3.71%
2026Q10.01-96.6%0.500.000.1%0.03%2.57%
2025Q40.40249.8%0.760.116.6%1.98%3.70%
2025Q30.01-98.6%0.480.000.3%0.09%2.44%
2025Q20.08-88.3%1.140.021.5%0.41%5.91%
2025Q10.28-45.6%1.720.085.3%1.36%9.37%
2024Q40.11-53.3%1.950.032.0%0.55%11.13%
2024Q30.68290.6%2.080.1911.3%3.24%11.89%
2024Q20.6598.5%1.580.1810.7%3.40%8.70%
2024Q10.5189.3%1.260.148.5%3.20%8.60%
2023Q40.248.8%1.020.074.4%1.64%7.35%
2023Q30.17-37.3%1.000.053.1%1.20%7.56%
2023Q20.33847.8%1.100.096.4%2.43%8.50%
2023Q10.27-29.5%0.810.085.6%2.12%6.55%
2022Q40.230.920.064.5%1.86%7.72%
2022Q30.28113.2%0.630.085.9%2.39%5.44%
2022Q20.03-84.6%0.480.010.6%0.27%4.21%
2022Q10.380.680.117.7%3.33%5.98%
2021Q4-0.060.28-0.02-1.3%-0.48%2.48%
2021Q30.130.010.042.6%1.09%0.10%
2021Q20.23-0.280.064.5%2.00%-2.40%
2021Q1-0.02-298.9%-0.59-0.00-0.4%-0.15%-5.17%
2020Q4-0.33-859.6%-0.56-0.09-7.9%-2.87%-4.78%
2020Q3-0.16-0.19-0.05-3.8%-1.41%-1.57%
2020Q2-0.09-130.3%-0.03-0.02-2.3%-0.72%-0.24%
2020Q10.01-97.3%0.340.000.2%0.07%2.89%
2019Q40.04-61.5%0.650.011.2%0.39%5.48%
2019Q30.00-100.0%0.72-0.00-0.1%-0.02%5.94%
2019Q20.29175.2%0.750.087.0%2.36%6.40%
2019Q10.32-9.8%0.570.099.2%2.69%4.77%
2018Q40.111193.1%0.610.032.9%0.95%5.30%
2018Q30.03-73.3%0.500.011.2%0.33%4.41%
2018Q20.10500.0%0.600.033.1%0.89%5.29%
2018Q10.3551.9%0.510.1010.7%3.11%4.50%
2017Q40.010.390.000.1%0.04%3.53%
2017Q30.1387.6%0.140.044.1%1.18%1.33%
2017Q20.020.080.000.6%0.16%0.75%
2017Q10.23-0.070.077.3%2.15%-0.56%
2016Q4-0.24-0.30-0.07-8.0%-2.16%
2016Q30.070.021.8%0.61%